IDH1 and glioblastoma: One study identified two distinct immune infiltration subtypes in GBM, with Gene Cluster A characterized by a hot immune phenotype, low IDH1 mutation frequency, elevated immune-related gene expression, and favorable prognosis and immunotherapy response, whereas Cluster B exhibited a cold immune phenotype, high expression of neuronal-related genes, low immune reactivity, and lacked such clinical benefits (60).